BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas will sit on a panel at the Biotechnologia 2007 Conference, in Greece, titled "IPOs and IPO-like Transactions in Global Markets".
News | 07. 11. 2008
